Preclinical CRO Market Share & Trends Analysis Report - 2032

Preclinical CRO Market - By Service (Bioanalysis & DMPK Studies, Toxicology Testing), By End-use (Biopharmaceutical Companies, Government & Academic Institutes, Medical Device Companies), By Region & Global Forecast, 2023 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology

1.1&nbsp;&nbsp;&nbsp; Methodology

1.2&nbsp;&nbsp;&nbsp; Market scope and definition

1.3&nbsp;&nbsp;&nbsp; Base estimates

1.4&nbsp;&nbsp;&nbsp; Forecast calculations

1.5&nbsp;&nbsp;&nbsp; COVID-19 impact at global level

1.6&nbsp;&nbsp;&nbsp; Data validation

1.7&nbsp;&nbsp;&nbsp; Data Sources

1.7.1&nbsp;&nbsp;&nbsp; Secondary

1.7.1.1&nbsp;&nbsp;&nbsp;Paid sources

1.7.1.2&nbsp;&nbsp;&nbsp;Unpaid sources

1.7.2&nbsp;&nbsp;&nbsp; Primary

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Preclinical CRO industry 3600 synopsis, 2018 - 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Service trends

2.1.3&nbsp;&nbsp;&nbsp; End-use trends

2.1.4&nbsp;&nbsp;&nbsp; Regional trends

Chapter 3&nbsp;&nbsp;&nbsp;Preclinical CRO Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry segmentation

3.2&nbsp;&nbsp;&nbsp; Industry landscape, 2018 - 2032

3.3&nbsp;&nbsp;&nbsp; Industry impact forces

3.3.1&nbsp;&nbsp;&nbsp; Growth drivers

3.3.1.1&nbsp;&nbsp;&nbsp;Increasing R&amp;D expenditure worldwide

3.3.1.2&nbsp;&nbsp;&nbsp;Growing outsourcing of R&amp;D activities

3.3.1.3&nbsp;&nbsp;&nbsp;Rising number of drugs in preclinical trails

3.3.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.3.2.1&nbsp;&nbsp;&nbsp;Stringent regulatory policies

3.4&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4.1&nbsp;&nbsp;&nbsp; By service

3.4.2&nbsp;&nbsp;&nbsp; By end-use

3.5&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.6&nbsp;&nbsp;&nbsp; Preclinical trial volume analysis

3.6.1&nbsp;&nbsp;&nbsp; preclinical trial volume analysis, by region, 2018 - 2021

3.6.2&nbsp;&nbsp;&nbsp; preclinical trial volume analysis, by indication, 2018 - 2021

3.6.3&nbsp;&nbsp;&nbsp; preclinical trial volume analysis, by phase of development, 2018 - 2021

3.7&nbsp;&nbsp;&nbsp; Regulatory landscape

3.7.1&nbsp;&nbsp;&nbsp; U.S.

3.7.2&nbsp;&nbsp;&nbsp; Europe

3.7.3&nbsp;&nbsp;&nbsp; Asia Pacific

3.7.3.1&nbsp;&nbsp;&nbsp;Singapore

3.7.3.2&nbsp;&nbsp;&nbsp;Malaysia

3.7.3.3&nbsp;&nbsp;&nbsp;Indonesia

3.7.3.4&nbsp;&nbsp;&nbsp;Thailand

3.7.3.5&nbsp;&nbsp;&nbsp;South Korea

3.7.3.6&nbsp;&nbsp;&nbsp;Philippines

3.8&nbsp;&nbsp;&nbsp; Clinical trials- Asia Pacific advantage

3.9&nbsp;&nbsp;&nbsp; Pricing Landscape

3.10&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.11&nbsp;&nbsp;&nbsp; Drug discovery and development process

3.12&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.13&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Company market share analysis, 2022

4.4&nbsp;&nbsp;&nbsp; Strategic dashboard, 2022

4.5&nbsp;&nbsp;&nbsp; Merger &amp; acquisition landscape

4.5.1&nbsp;&nbsp;&nbsp; Merger &amp; acquisition deals in the CRO industry, 2018 &ndash; 2022

4.5.2&nbsp;&nbsp;&nbsp; Completed contract research organization merger &amp; acquisition deals, 2018-2021

4.5.3&nbsp;&nbsp;&nbsp; Influence of private equity in CRO mergers &amp; acquisitions

4.5.3.1&nbsp;&nbsp;&nbsp;PRA Health Sciences

4.5.3.2&nbsp;&nbsp;&nbsp;Medpace, Inc.

4.5.3.3&nbsp;&nbsp;&nbsp;PPD, Inc.

4.5.3.4&nbsp;&nbsp;&nbsp;Parexel International Corporation

4.5.4&nbsp;&nbsp;&nbsp; Impact of industry consolidation on the overall market

4.5.5&nbsp;&nbsp;&nbsp; Analyst insights

Chapter 5&nbsp;&nbsp;&nbsp;Preclinical CRO Market, By Service

5.1&nbsp;&nbsp;&nbsp; Key segment trends

5.2&nbsp;&nbsp;&nbsp; Bioanalysis &amp; DMPK studies

5.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.3&nbsp;&nbsp;&nbsp; Toxicology testing

5.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.4&nbsp;&nbsp;&nbsp; Others

5.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6&nbsp;&nbsp;&nbsp;Preclinical CRO Market, By End-use

6.1&nbsp;&nbsp;&nbsp; Key segment trends

6.2&nbsp;&nbsp;&nbsp; Biopharmaceutical companies

6.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.3&nbsp;&nbsp;&nbsp; Government and academic institutes

6.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.4&nbsp;&nbsp;&nbsp; Medical devices companies

6.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.5&nbsp;&nbsp;&nbsp; Others

6.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7&nbsp;&nbsp;&nbsp;Preclinical CRO Devices Market, By Region

7.1&nbsp;&nbsp;&nbsp; Key regional trends

7.2&nbsp;&nbsp;&nbsp; North America

7.2.1&nbsp;&nbsp;&nbsp; U.S.

7.2.2&nbsp;&nbsp;&nbsp; Canada

7.3&nbsp;&nbsp;&nbsp; Europe

7.3.1&nbsp;&nbsp;&nbsp; Germany

7.3.2&nbsp;&nbsp;&nbsp; UK

7.3.3&nbsp;&nbsp;&nbsp; France

7.3.4&nbsp;&nbsp;&nbsp; Spain

7.3.5&nbsp;&nbsp;&nbsp; Italy

7.4&nbsp;&nbsp;&nbsp; Asia Pacific

7.4.1&nbsp;&nbsp;&nbsp; Japan

7.4.2&nbsp;&nbsp;&nbsp; China

7.4.3&nbsp;&nbsp;&nbsp; India

7.4.4&nbsp;&nbsp;&nbsp; Australia

7.5&nbsp;&nbsp;&nbsp; Latin America

7.5.1&nbsp;&nbsp;&nbsp; Brazil

7.5.2&nbsp;&nbsp;&nbsp; Mexico

7.6&nbsp;&nbsp;&nbsp; MEA

7.6.1&nbsp;&nbsp;&nbsp; South Africa

7.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

Chapter 8&nbsp;&nbsp;&nbsp;Company Profiles

8.1&nbsp;&nbsp;&nbsp; Charles River Laboratory, Inc.

8.2&nbsp;&nbsp;&nbsp; Laboratory Corporation of America, Inc.

8.3&nbsp;&nbsp;&nbsp; Pharmaceutical Product Development (PPD), LLC (a part of Thermo Fisher Scientific),

8.4&nbsp;&nbsp;&nbsp; ICON plc

8.5&nbsp;&nbsp;&nbsp; Eurofins Scientific

8.6&nbsp;&nbsp;&nbsp; Parexel International Corporation

8.7&nbsp;&nbsp;&nbsp; Medpace, Inc.

8.8&nbsp;&nbsp;&nbsp; WuXi AppTec

8.9&nbsp;&nbsp;&nbsp; SGS SA

8.10&nbsp;&nbsp;&nbsp; Altasciences Company, Inc. 
&nbsp;

Preclinical CRO Market

Get a free sample of this report

Industries

Information

Link

Global Headquarters